Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum

Neurochemistry International

Volumn 50, Issue 1, 2007, Pages 164-171

  Furian, Ana Flávia ^a   Fighera, Michele Rechia ^a   Oliveira, Mauro Schneider ^a   Ferreira, Ana Paula de Oliveira ^a   Fiorenza, Natália Gindri ^a   de Carvalho Myskiw, Jociane ^a   Petry, João Carlos ^a   Coelho, Rafael Correa ^a   Mello, Carlos Fernando ^a   Royes, Luiz Fernando Freire ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Convulsion; Methylene blue; Methylmalonate; Na+,K+ ATPase; Protein carbonylation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); METHYLENE BLUE; METHYLMALONIC ACID; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; CARBONYLATION; CONTROLLED STUDY; CONVULSION; CORPUS STRIATUM; DRUG DOSE COMPARISON; DRUG EFFECT; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; SEIZURE; STATISTICAL ANALYSIS;

ANIMALS; CORPUS STRIATUM; ELECTROENCEPHALOGRAPHY; MALE; METHYLENE BLUE; METHYLMALONIC ACID; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEIZURES;

EID: 33845326724     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.07.012     Document Type: Article

References (59)

1. Aeschlimann C., Cerny T., and Küpfer A. Inhibition of monoamine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue. Drug Metab. Dispos. 12 (1998) 1336-1339
2. Beal M.F. Oxidative modified proteins in aging and disease. Free Radic. Biol. Med. 32 9 (2002) 797-803
3. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272 33 (1997) 20313-20316
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Brusque A.M., Borba Rosa R., Schuck P.F., Ribeiro C.A.J., Silva C.G., Wannmacher C.M.D., Dutra-Filho C.S., Wyse A.T.S., Briones P., and Wajner M. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 40 7 (2002) 593-601
6. Callaway N.L., Riha P.D., Wrubel K.M., McCollum D., and Gonzalez-Lima F. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci. Lett. 332 2 (2002) 83-86
7. Callaway N.L., Riha P.D., Bruchey A.K., Munshi Z., and Gonzalez-Lima F. Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol. Biochem. Behav. 77 1 (2004) 175-181
8. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., McCollum D., and Gonzalez-Lima F. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate. J. Neurochem. 71 (2002) 1524-1532
9. Cavalheiro E.A., de Feo M.R., and Mecarelli O. Age-related anticonvulsant activity of NMDA in the rat caudate-putamen. Brain Res. 67 (1992) 371-374
10. Dalle-Donne I., Giustarini D., and Colombo R. Protein carbonylation in human diseases. Trends Mol. Med. 9 (2003) 169-176
11. Dawson V.L., Dawson T.L., London E.D., Bredt D.H., and Synder S.H. Nitric oxide mediates glutamate toxicity in primary cortical cultures. Proc. Natl. Acad. Sci. 88 (1991) 6368-6371
12. de Mello C.F., Begnini J., Jiménez-Bernal R.E., Rubin M.A., de Bastiani J., da Costa Jr. E.M., and Wajner M. Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res. 721 (1996) 120-125
13. Demandt M., and Wandt H. Successful treatment with methylene blue of ifosfamide induced central nervous system effects. Dtsch. Med. Wochenschr. 121 17 (1996) 575
14. Esplugues J.V. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 135 (2002) 1079-1095
15. Fenton W.A., Gravel R.A., and Rosenblatt D.S. Disorders of propionate and methylmalonate metabolism. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eight ed. (2001), McGraw-Hill, New York 2165-2193
16. Fighera M.R., Bonini J.S., Oliveira T.G., Frussa-Filho R., Rocha J.B.T., Dutra-Filho C.S., Rubin M.A., and Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell Biol. 35 (2003) 465-473
17. Fighera M.R., Queiroz C.M., Stracke M.P., Nin Bauer M.C., Gonzales-Rodriguez L.L., Frussa-Filho R., Wajner M., and de Mello C.F. Ascorbic acid and α-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport 10 (1999) 2039-2043
18. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66 (1925) 375-400
19. Fleck J., Ribeiro M.C.P., Schneider C.M., Sinhorin V.D.G., Rubin M.A., and Mello C.F. Intrastriatal malonate administration induces convulsive behaviour in rats. J. Inherit. Metab. Dis. 27 (2004) 211-219
20. Fridovich I. Superoxide anion radical, superoxide dismutases, and related matters. J. Biol. Chem. 272 30 (1997) 18515-18517
21. +-ATPase activity by oxygen free radicals. Neuroreport 29 (1995) 333-337
22. Kelner M.J., Bagnell R., Hale B., and Alexander N.M. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch. Biochem. Biophys. 262 2 (1988) 422-426
23. Kölker S., Schwab M., Horster F., Sauer S., Hinz A., Wolf N.I., Mayatepek E., Hoffmann G.F., Smeitink J.A., and Okun J.G. Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J. Biol. Chem. 278 47 (2003) 47388-47393
24. Küpfer A., Aeschlimann C., Wermuth B., and Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 343 (1994) 763-764
25. Küpfer A., Aeschlimann C., and Cerny T. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy. Eur. J. Clin. Pharmacol. 50 4 (1996) 249-252
26. 2+ and respiratory chain complex II inhibition. J. Neurochem. 90 (2004) 1025-1035
27. +-ATPase activity in the rat striatum and cerebral cortex. Epilepsia 44 (2003) 761-767
28. Marisco P., Ribeiro M.C., Bonini J.S., Lima T.T., Mann K.C., Brener G.M., Dutra-Filho C.S., and Mello C.F. Ammonia potentiates methylmalonic acid-induced convulsions and TBARS production. Exp. Neurol. 182 (2003) 455-460
29. Matthews R.T., Yang L., and Beal M.F. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp. Neurol. 143 (1997) 282-286
30. Mayer B., Brunner F., and Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45 2 (1992) 367-374
31. Mayer B., Brunner F., and Schmidt K. Novel actions of methylene blue. Eur. Heart J. 14 1 (1993) 22-26
32. McLaughlin B.A., Nelson D., Silver A., Erecinska M., and Chesselet M.F. Methylmalonate toxicity in primary neuronal cultures. Neuroscience 86 (1998) 279-290
33. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 1 (2001) 62-71
34. Morel P., Fauconneau B., and Page G. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neurosci. Res. 32 (1998) 171-179
35. Okun J.G., Hörster F., Farkas L.M., Fleyh P., Hinz A., Sauer S., Hoffmann G.F., Unsicker K., Mayatepek E., and Kölker S. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and tricarboxylic acid cycle, and synergistically acting excitotoxicity. J. Biol. Chem. 277 (2002) 14674-14680
36. Oliveira M.S., Furian A.F., Royes L.F.F., Fighera M.R., Fiorenza N.G., Myskiw J.C., and Mello C.F. Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience 128 4 (2004) 721-728
37. Pavarana N., Nortilli R., Valcamonico F., Romito S., Zanoni T., and Cetto G. Ifosfamide encephalopathy: a case report. Tumori 91 2 (2005) 197-200
38. Paxinos G. The Rat Brain in Stereotaxic Coordinates. second ed. (1986), Academic Press, San Diego
39. Pelgrims J., De Vos F., and Van de Brande J. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br. J. Cancer. 82 2 (2000) 291-294
40. Raj A.B., Bertolone S.J., and Jaffe N. Methylene blue reversal of ifosfamide-related encephalopathy. J. Pedriatr. Hematol. Oncol. 26 2 (2004) 116-117
41. Riedel W., Lang U., Oetjen U., Schlapp U., and Shibata M. Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol. Cell. Biochem. 247 (2003) 83-94
42. Riha P.D., Bruchey A.K., Echevarria D.J., and Gonzalez-Lima F. Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur. J. Pharmacol. 511 (2005) 151-158
43. A receptor function in the rat cerebral cortex and cerebellar granule cells. Neuroscience 74 (1996) 99-105
44. Royes L.F.F., Fighera M.R., Furian A.F., Oliveira M.S., da Silva L.G.M., Malfatti C.R.M., Schneider P.H., Braga A.L., Wajner M., and Mello C.F. Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. Neuroscience 118 (2003) 1079-1090
45. Royes L.F.F., Fighera M.R., Furian A.F., Oliveira M.S., Fiorenza N.G., Myskiw J.C., Frussa-Filho R., and Mello C.F. Involvement of NO in the convulsive behavior and oxidative damage induced by the intrastriatal injection of methylmalonate. Neurosci. Lett. 376 2 (2005) 116-120
46. Salaris S.C., Babbs C.F., and Voorhees W.D. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem. Pharmacol. 42 3 (1991) 499-506
47. Schuck P.F., Rosa R.B., Pettenuzzo L.F., Sitta A., Wannmacher C.M., Wyse A.T., and Wajner M. Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid. Neurochem. Int. 45 5 (2004) 661-667
48. Schulz J.B., Huang P.L., Matthews R.T., Passov D., Fishman M.C., and Beal M.F. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67 (1996) 430-433
49. Toyoshima S., Watanable F., Saido H., Miyatake K., and Nakano Y. Methylmalonic acid inhibits respiration in rat liver mitochondria. J. Nutr. 125 (1995) 2846-2850
50. Turner A.R., Duong C.D., and Good D.J. Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy. Clin. Oncol. (R. Coll. Radiol.) 15 7 (2003) 435-439
51. Visarius T.M., Stucki J.W., and Lauterburg B.H. Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett. 412 (1997) 157-160
52. Visarius T.M., Stucki J.W., and Lauterburg B.H. Inhibition and stimulation of long chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J. Pharmacol. Exp. Ther. 289 (1999) 820-824
53. Volke V., Wegener G., Vasar E., and Rosenberg R. Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res. 826 (1999) 303-305
54. Wajner M., Dutra J.C., Cardoso S.E., Wannmacher C.M.D., and Motta E.R. Effect of methylmalonate on in vitro lactate release and carbon dioxide production by brain of suckling rats. J. Inherit. Metab. Dis. 15 (1992) 92-96
55. Wajner M., Latini A., Wyse A.T., and Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 27 (2004) 427-448
56. +-ATPase activity in cerebral cortex of rats. Neuroreport 11 (2000) 1010-1014
57. Yan L.J., Traber M.G., and Packer L. Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal. Biochem. 228 (1995) 349-351
58. A receptors. Neurosci. Lett. 180 (1994) 239-242
59. Zulian G.B., Tullen F., and Maton B. Methylene blue for ifosfamide-associated encephalopathy. N. Engl. J. Med. 332 (1995) 1239-1240